Gordon, K., Warren, R., Gottlieb, A., Blauvelt, A., Thaci, D., Leonardi, C., Poulin, Y., Boehnlein, M., Kavanagh, S., Arendt, C. and Reich, K. 2019. Long-Term Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks in Patients with Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S36. DOI:https://doi.org/10.25251/skin.3.supp.36.